Cannabis + Alcohol on Impairment

"Data provided by clinicaltrials.gov indicates that this research is currently enrolling participants. The initial posting was made on February 17th 2022 and the last revision was completed on April 11th of the same year."

"This clinical trial targets applicants between the ages of 21 and 50. For patients outside that demographic, there are 25 studies for those below 18 years old and 77 for seniors aged over 65."

"Since this is a Phase 1 clinical trial, the safety of cannabis has been assessed at a low score of one. This reflects that there is only limited data proving its efficacy and protective qualities."

"The primary measure of success in this 7.5-hour trial will be Driving performance as assessed by standard deviation of lateral position (SDLP). Additional criteria include a Field Sobriety Test - Score on Horizontal Gaze Nystagmus Test, Driving Performance (total rule violations), and Drug Effect Questionnaire - Want more scores between 0 and 100 with none/extreme designation."

"Affirmative. Clinicaltrials.gov shows that this clinical trial, initially posted on February 17th 2022, is actively recruiting participants at the moment. The research team needs to bring in approximately 90 volunteers from 1 site."

"This trial is looking for 90 volunteers, between the ages of 21 and 50 that have a history of hashish abuse. In order to be admitted into this study participants must meet certain criteria: submit informed consent in writing, display general health during physical examination and screening tests (urine/blood), not pregnant or nursing if female with negative pregnancy test results at Screening Visit/study visits respectively, BMI within 19-36kg/m2 range, no blood donation in last 30 days,, report 5+ cannabis uses past year, present negative urine drug test (excluding THC) + breath alcohol test(0% BAC @Screening/+"

"At this time, 11 trials for Cannabis are in their last stage of research with 67 total studies being conducted. The majority of these investigations are based out of Lexington, Kentucky but an additional 1,010 sites have been identified to be researching the drug."

"Cannabis is generally employed to treat hypertrophic cardiomyopathy, but its medicinal benefits can also be utilised for communicable diseases and ethylene glycol therapy as well as skin disinfection."